Head-to-head · Cost-Efficiency Index
Trinity Meds vs HealthOn
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Trinity Meds
Cost-first shoppers who want price-sensitive shoppers comfortable prepaying 6-12 months to lock in the lowest per-month rate.
Visit Trinity MedsHealthOn
Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Visit HealthOnThe verdict
Trinity Meds takes it, leading the Cost-Efficiency Index 58 to 57. Trinity Meds (trinitymeds.com) is a LegitScript-certified, 50-state telehealth platform prescribing compounded semaglutide ($99/mo) and tirzepatide ($149/mo) through the OpenLoop Health provider network. HealthOn still earns a C — Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Trinity Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Trinity Meds | HealthOn |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 57/100 |
| Semaglutide / mo | $99/mo (starting dose, compounded) | $189/mo (1.5 mg dose, compounded) |
| Tirzepatide / mo | $149/mo (starting dose, compounded) | $295/mo (10 mg dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,268 |
| Tirzepatide / yr (modeled) | $1,788 | $3,540 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #294 | #297 |
Trinity Meds
58/100Where the value is
- LegitScript Certified with a displayed seal
- Transparent tiered pricing table (month-to-month through 12-month prepay) all shown up front
- Four named, identifiable compounding pharmacy partners
The tradeoffs
- Headline $99/$149 pricing sits under a manufactured-urgency 'Was $299' countdown-timer promo with an unverifiable anchor price
- Cheapest per-month rates require 12-month prepayment, not simple monthly billing
HealthOn
57/100Where the value is
- Both compounded semaglutide ($189/mo) and tirzepatide ($295/mo) are priced on their own dedicated product pages, not gated behind an intake
- Quarterly and 12-month prepay options are disclosed with real dollar savings ($549/quarter and $837/quarter respectively)
- Independent third-party batch testing for potency, sterility, pH, and endotoxins is disclosed as a stated policy
The tradeoffs
- The site's sitewide 'Starting at $155/mo*' nav banner is not specific to either medication and requires a 12-month prepay commitment to actually reach — a shopper skimming only the banner will underestimate the real starting cost by $34-140/mo
- No named prescriber, medical director, or specific compounding pharmacy anywhere on the pages checked
Regulatory note: the FDA issued a warning letter to Healthon Inc. dba Healthon in September 2025. We still list and link to HealthOn; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.